8 Leukemia Clinical Trials in Mesa, AZ (2026)

Q: How do I join a clinical trial in Mesa?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Mesa research site will contact you.

Recruiting Leukemia Studies in Mesa

NCT03959085Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial al...

Mesa, AZPHASE35,951 participantsChildren's Oncology Group

View Study Details

NCT07222566Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

This study is being done to find out if a new medicine called PF-08634404, when given with chemotherapy, works better than the present standard treatment (pembrolizumab with chemotherapy) for adults w...

Mesa, AZPHASE31,410 participantsPfizer

View Study Details

NCT04293562Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

This phase III trial compares standard chemotherapy to therapy with liposome-encapsulated daunorubicin-cytarabine (CPX-351) and/or gilteritinib for patients with newly diagnosed acute myeloid leukemia...

Mesa, AZPHASE31,186 participantsChildren's Oncology Group

View Study Details

NCT04726241Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from pati...

Mesa, AZPHASE1960 participantsPedAL BCU, LLC

View Study Details

NCT04546399Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come ...

Mesa, AZPHASE2461 participantsNational Cancer Institute (NCI)

View Study Details

NCT06317662Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

This phase II trial tests the addition of venetoclax and/or blinatumomab to usual chemotherapy for treating infants with newly diagnosed acute lymphoblastic leukemia (ALL) with a KMT2A gene rearrangem...

Mesa, AZPHASE2153 participantsNational Cancer Institute (NCI)

View Study Details

NCT04142437Recruiting

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

In this observational study researcher want to learn more about the effectiveness of drug VITRAKVI (generic name: larotrectinib) and how well the drug is tolerated during routine use in patients with ...

Mesa, AZ150 participantsBayer

View Study Details

NCT02981628Recruiting

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with B-lymphoblastic lymphoma or CD22 positive B acute lymphoblastic leukemia that has come back (relapsed...

Mesa, AZPHASE280 participantsChildren's Oncology Group

View Study Details

About Leukemia Clinical Trials in Mesa

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 8 leukemia clinical trials recruiting participants in Mesa, AZ. These studies are seeking a combined 10,351 participants. Research is being sponsored by Children's Oncology Group, Pfizer, PedAL BCU, LLC and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Mesa — FAQ

Are there leukemia clinical trials in Mesa?

Yes, there are 8 leukemia clinical trials currently recruiting in Mesa, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Mesa?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mesa research site will contact you about next steps.

Are clinical trials in Mesa free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mesa studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 8 active trials in Mesa are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 21, 2026 from ClinicalTrials.gov